Effects of Melatonin on the Body Composition, Physical Performance, and Blood Erythrocyte Indexes of C57Bl/6J Mice Exposed to Continuous Illumination


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Male C57Bl/6J mice were exposed to daily 24-h illumination over 14 days and daily intragastrically received melatonin (1 mg/kg) or water (placebo). Controls were kept under standard day/night (14/10 h) conditions. Melatonin prevented the development of anemia in mice exposed to continuous illumination, which was proven by higher blood hemoglobin levels by the end of the experiment in melatonin-treated animals in comparison with the placebo group. Studies by the low-field NMR spectrometry detected lower lean body mass, total body water, and especially, fat content (by ~13%) in animals receiving placebo. Melatonin treatment led to an increase in the lean body mass and total body water on day 7 (in comparison with the placebo group) without affecting fat mass. On day 14 of continuous illumination, lean body mass increased in comparison with the corresponding parameter in the control and placebo groups. Melatonin had no effect on the physical endurance of mice exposed to continuous illumination (assessed by the grid hanging test).

About the authors

S. V. Michurina

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Author for correspondence.
Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

I. Yu. Ishchenko

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

M. A. Korolev

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

A. Yu. Letyagin

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk; Novosibirsk

L. N. Rachkovskaya

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

A. S. Khotskina

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

N. V. Khotskin

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

S. O. Maslennikova

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

E. L. Zavjalov

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies